28081741|t|Depletion of NFBD1 / MDC1 Induces Apoptosis in Nasopharyngeal Carcinoma Cells Through the p53 - ROS - Mitochondrial Pathway
28081741|a|NFBD1, a signal amplifier of the p53 pathway, is vital for protecting cells from p53 -mediated apoptosis and the early phase of DNA damage response under normal culture conditions. Here we investigated its expression in patients with nasopharyngeal carcinoma (NPC), and we describe the biological functions of the NFBD1 gene. We found that NFBD1 mRNA and protein were more highly expressed in NPC tissues than in nontumorous tissues. To investigate the function of NFBD1, we created NFBD1 - depleted NPC cell lines that exhibited decreased cellular proliferation and colony formation, an increase in their rate of apoptosis, and an enhanced sensitivity to chemotherapeutic agents compared with in vitro controls. However, N-acetyl cysteine (NAC) and downregulation of p53 expression could partially reverse the apoptosis caused by the loss of NFBD1. Further analysis showed that loss of NFBD1 resulted in increased production of intracellular reactive oxygen species (ROS) depending on p53, which subsequently triggered the mitochondrial apoptotic pathwa y. Using a xenograft model in nude mice, we showed that silencing NFBD1 also significantly inhibited tumor growth and led to apoptosis. Taken together, our data suggest that inhibition of NFBD1 in NPC could be therapeutically useful.
28081741	13	18	NFBD1	T017	UMLS:C1427378
28081741	21	25	MDC1	T017	UMLS:C1427378
28081741	34	43	Apoptosis	T038	UMLS:C0162638
28081741	47	71	Nasopharyngeal Carcinoma	T038	UMLS:C2931822
28081741	72	77	Cells	T017	UMLS:C0007634
28081741	90	93	p53	T103	UMLS:C0080055
28081741	96	99	ROS	T103	UMLS:C0162772
28081741	102	123	Mitochondrial Pathway	T038	UMLS:C3270989
28081741	124	129	NFBD1	T017	UMLS:C1427378
28081741	157	168	p53 pathway	T038	UMLS:C2756034
28081741	183	199	protecting cells	T038	UMLS:C0524828
28081741	205	208	p53	T103	UMLS:C0080055
28081741	219	228	apoptosis	T038	UMLS:C0162638
28081741	252	271	DNA damage response	T038	UMLS:C1155291
28081741	278	303	normal culture conditions	T058	UMLS:C0007585
28081741	330	340	expression	T038	UMLS:C1171362
28081741	358	382	nasopharyngeal carcinoma	T038	UMLS:C2931822
28081741	384	387	NPC	T038	UMLS:C2931822
28081741	410	430	biological functions	T038	UMLS:C3714634
28081741	438	448	NFBD1 gene	T017	UMLS:C1427378
28081741	464	469	NFBD1	T017	UMLS:C1427378
28081741	470	474	mRNA	T103	UMLS:C0035696
28081741	479	486	protein	T103	UMLS:C0033684
28081741	504	513	expressed	T038	UMLS:C0017262
28081741	517	520	NPC	T038	UMLS:C2931822
28081741	521	528	tissues	T017	UMLS:C1292533
28081741	537	548	nontumorous	T033	UMLS:C0243095
28081741	549	556	tissues	T017	UMLS:C1292533
28081741	577	585	function	T038	UMLS:C1527118
28081741	589	594	NFBD1	T017	UMLS:C1427378
28081741	607	612	NFBD1	T017	UMLS:C1427378
28081741	624	627	NPC	T038	UMLS:C2931822
28081741	628	638	cell lines	T017	UMLS:C0007600
28081741	664	686	cellular proliferation	T038	UMLS:C0596290
28081741	691	697	colony	T017	UMLS:C1947989
28081741	738	747	apoptosis	T038	UMLS:C0162638
28081741	780	803	chemotherapeutic agents	T103	UMLS:C0729502
28081741	846	863	N-acetyl cysteine	T103	UMLS:C0001047
28081741	865	868	NAC	T103	UMLS:C0001047
28081741	874	888	downregulation	T038	UMLS:C0013081
28081741	892	906	p53 expression	T038	UMLS:C1171362
28081741	935	944	apoptosis	T038	UMLS:C0162638
28081741	967	972	NFBD1	T017	UMLS:C1427378
28081741	1011	1016	NFBD1	T017	UMLS:C1427378
28081741	1053	1066	intracellular	T082	UMLS:C0178719
28081741	1067	1090	reactive oxygen species	T103	UMLS:C0162772
28081741	1092	1095	ROS	T103	UMLS:C0162772
28081741	1110	1113	p53	T103	UMLS:C0080055
28081741	1148	1178	mitochondrial apoptotic pathwa	T038	UMLS:C3269143
28081741	1190	1205	xenograft model	T038	UMLS:C1520166
28081741	1209	1218	nude mice	T204	UMLS:C0025932
28081741	1235	1244	silencing	T038	UMLS:C0598496
28081741	1245	1250	NFBD1	T017	UMLS:C1427378
28081741	1304	1313	apoptosis	T038	UMLS:C0162638
28081741	1367	1372	NFBD1	T017	UMLS:C1427378
28081741	1376	1379	NPC	T038	UMLS:C2931822
28081741	1389	1404	therapeutically	T058	UMLS:C0087111